Literature DB >> 29859248

Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper.

Andrea Poli1, Carlo M Barbagallo2, Arrigo F G Cicero3, Alberto Corsini4, Enzo Manzato5, Bruno Trimarco6, Franco Bernini7, Francesco Visioli8, Alfio Bianchi9, Giuseppe Canzone10, Claudio Crescini11, Saula de Kreutzenberg12, Nicola Ferrara13, Marco Gambacciani14, Andrea Ghiselli15, Carla Lubrano16, Giuseppe Marelli17, Walter Marrocco18, Vincenzo Montemurro19, Damiano Parretti20, Roberto Pedretti21, Francesco Perticone22, Roberto Stella23, Franca Marangoni24.   

Abstract

Current evidence shows that cholesterol management either reduces the likelihood of cardiovascular disease (CVD) or slows down its progression. Hence, it is important that all health professionals make appropriate use of all the available intervention strategies to control risk factors: from dietary improvement and positive lifestyle changes to the use of functional foods, food supplements, and drugs. This review examines the effect of the most frequently occurring cholesterol-lowering substances in functional foods or in supplements across Europe, namely plant sterols and stanols, monacolin K found in red yeast rice, berberine and beta-glucans. We conclude that currently available supplements and functional foods can effectively reduce plasma LDL cholesterol levels by about 5 to 25%, either alone or in combination. Suitable candidates for these products are mainly individuals at low absolute cardiovascular risk at a young age or according to classic algorithms. Of note, despite being freely available for purchase, these products should be used following shared agreement between the physician and the patient ("concordance").
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiovascular risk; Cholesterol; Food supplements; Functional foods; LDL cholesterol; Primary prevention

Mesh:

Substances:

Year:  2018        PMID: 29859248     DOI: 10.1016/j.phrs.2018.05.015

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  34 in total

Review 1.  Low Density Lipoprotein (LDL) Cholesterol as a Causal Role for Atherosclerotic Disease: Potential Role of PCSK9 Inhibitors.

Authors:  Rita Del Pinto; Davide Grassi; Giuliana Properzi; Giovambattista Desideri; Claudio Ferri
Journal:  High Blood Press Cardiovasc Prev       Date:  2019-06-24

Review 2.  Red Yeast Rice for Hypercholesterolemia.

Authors:  Arrigo F G Cicero; Federica Fogacci; Maciej Banach
Journal:  Methodist Debakey Cardiovasc J       Date:  2019 Jul-Sep

3.  PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021.

Authors:  Maciej Banach; Paweł Burchardt; Krzysztof Chlebus; Piotr Dobrowolski; Dariusz Dudek; Krzysztof Dyrbuś; Mariusz Gąsior; Piotr Jankowski; Jacek Jóźwiak; Longina Kłosiewicz-Latoszek; Irina Kowalska; Maciej Małecki; Aleksander Prejbisz; Michał Rakowski; Jacek Rysz; Bogdan Solnica; Dariusz Sitkiewicz; Grażyna Sygitowicz; Grażyna Sypniewska; Tomasz Tomasik; Adam Windak; Dorota Zozulińska-Ziółkiewicz; Barbara Cybulska
Journal:  Arch Med Sci       Date:  2021-11-08       Impact factor: 3.318

Review 4.  Prevention and Treatment of Cardiovascular Diseases with Plant Phytochemicals: A Review.

Authors:  Rakesh Kumar Bachheti; Limenew Abate Worku; Yilma Hunde Gonfa; Meseret Zebeaman; D P Pandey; Archana Bachheti
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-04       Impact factor: 2.650

5.  The Effects of a New Generation of Nutraceutical Compounds on Lipid Profile and Glycaemia in Subjects with Pre-hypertension.

Authors:  Alberto Mazza; Laura Schiavon; Gianluca Rigatelli; Gioia Torin; Salvatore Lenti
Journal:  High Blood Press Cardiovasc Prev       Date:  2019-07-27

6.  Preliminary Results of CitraVes™ Effects on Low Density Lipoprotein Cholesterol and Waist Circumference in Healthy Subjects after 12 Weeks: A Pilot Open-Label Study.

Authors:  Stefania Raimondo; Dragana Nikolic; Alice Conigliaro; Gianluca Giavaresi; Bruna Lo Sasso; Rosaria Vincenza Giglio; Roberta Chianetta; Mauro Manno; Samuele Raccosta; Valeria Corleone; Giovanni Ferrante; Roberto Citarrella; Manfredi Rizzo; Giacomo De Leo; Marcello Ciaccio; Giuseppe Montalto; Riccardo Alessandro
Journal:  Metabolites       Date:  2021-04-27

7.  Metabolic composition and authenticity evaluation of bergamot essential oil assessed by nuclear magnetic resonance spectroscopy.

Authors:  Rosachiara A Salvino; Christie Aroulanda; Giovanni De Filpo; Giorgio Celebre; Giuseppina De Luca
Journal:  Anal Bioanal Chem       Date:  2022-01-19       Impact factor: 4.142

8.  Traditional Brazilian Diet and Olive Oil Reduce Cardiometabolic Risk Factors in Severely Obese Individuals: A Randomized Trial.

Authors:  Annelisa Silva E Alves de Carvalho Santos; Ana Paula Dos Santos Rodrigues; Lorena Pereira de Souza Rosa; Matias Noll; Erika Aparecida Silveira
Journal:  Nutrients       Date:  2020-05-14       Impact factor: 5.717

Review 9.  Naturally Occurring PCSK9 Inhibitors.

Authors:  Maria Pia Adorni; Francesca Zimetti; Maria Giovanna Lupo; Massimiliano Ruscica; Nicola Ferri
Journal:  Nutrients       Date:  2020-05-16       Impact factor: 5.717

10.  Prevention and Treatment of Atherosclerosis: The Use of Nutraceuticals and Functional Foods.

Authors:  Francesco Visioli; Andrea Poli
Journal:  Handb Exp Pharmacol       Date:  2022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.